Search research articles
Contact Us
Filters
Showing results (1-10 of 200) with videos related to
Page
of 20
Sort By:
The Journal of Infectious Diseases
|
November 9, 2002
Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease
Steven Jacobson
Virulence
|
December 24, 2010
The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease
Steven Jacobson
Neurologic Clinics
|
July 29, 2008
Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy
Unsong Oh, Steven Jacobson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 9, 2016
Editorial
Avindra Nath, Steven Jacobson
Frontiers in Microbiology
|
May 21, 2019
Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis
Satoshi Nozuma, Steven Jacobson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 9, 2016
Cytokine Therapies in Neurological Disease
Shila Azodi, Steven Jacobson
Herpes : the Journal of the IHMF
|
July 20, 2005
Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease
Julie Fotheringham, Steven Jacobson
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
July 27, 2010
Viral infections of the central nervous system: pathogenesis to therapeutics
Samantha S Soldan, Steven Jacobson
Retrovirology
|
December 1, 2019
Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Yoshimi Enose-Akahata, Steven Jacobson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 2, 2016
Vaccinations for Neuroinfectious Disease: A Global Health Priority
Emily C Leibovitch, Steven Jacobson
Page
of 20
Search research articles
Search
Showing results (1-10 of 200) with videos related to
Sort By:
Page
of 20
The Journal of Infectious Diseases
|
November 9, 2002
Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease
Steven Jacobson
Virulence
|
December 24, 2010
The NK cell as a new player in the pathogenesis of HTLV-I associated neurologic disease
Steven Jacobson
Neurologic Clinics
|
July 29, 2008
Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy
Unsong Oh, Steven Jacobson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 9, 2016
Editorial
Avindra Nath, Steven Jacobson
Frontiers in Microbiology
|
May 21, 2019
Neuroimmunology of Human T-Lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis
Satoshi Nozuma, Steven Jacobson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 9, 2016
Cytokine Therapies in Neurological Disease
Shila Azodi, Steven Jacobson
Herpes : the Journal of the IHMF
|
July 20, 2005
Human herpesvirus 6 and multiple sclerosis: potential mechanisms for virus-induced disease
Julie Fotheringham, Steven Jacobson
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
July 27, 2010
Viral infections of the central nervous system: pathogenesis to therapeutics
Samantha S Soldan, Steven Jacobson
Retrovirology
|
December 1, 2019
Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Yoshimi Enose-Akahata, Steven Jacobson
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
July 2, 2016
Vaccinations for Neuroinfectious Disease: A Global Health Priority
Emily C Leibovitch, Steven Jacobson
Page
of 20